Skip to main content
LUCD logo
LUCD
(NASDAQ)
Lucid Diagnostics Inc.
$0.94-- (--)
Loading... - Market loading

Lucid Diagnostics (LUCD) Stock Price & Financial Analysis

Lucid Diagnostics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.93 - $0.96
52-Week High$1.63
52-Week Low$0.86
Open$0.94
Volume1.02M
Average Volume (3M)926.55K
Market Cap95.78M
Shares Outstanding101.95M
Price to Sales (P/S)18.66
Price to Book (P/B)23.94
EV/EBITDA-2.15
Revenue (TTM)5.13M
Net Income (TTM)-45.01M
Free Cash Flow (TTM)-46.44M
EPS (TTM)$-0.38
Profit Margin-876.72%
Operating Margin-959.64%
Return on Equity (ROE)-1125.28%
Debt to Equity6.70
50-Day MA$0.98
200-Day MA$1.11
52-Week Change-31.42%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lucid Diagnostics

What is the current stock price for LUCD?

As of the latest trading session, LUCD stock trades at $0.94. The 52-week range is $0.86–$1.63, with a day range of $0.93–$0.96.

What is the P/E ratio for LUCD?

The P/E ratio (Price-to-Earnings) for LUCD is shown in the Key Statistics section. This valuation metric helps compare Lucid Diagnostics Inc. to industry peers.

Does LUCD pay dividends?

Lucid Diagnostics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LUCD?

Analyst ratings and recommendations for LUCD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of LUCD?

Lucid Diagnostics's market capitalization is $95.8M, classifying it as a micro-cap company. Lucid Diagnostics operates in the Healthcare sector within the Medical Devices industry.